Reported 608,536 shares, down 210,209 (25.7%) from the prior quarter.
Reported value -67.9%; share count -25.7% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 2595000 |
| 2022-03-31 | 834000 |
| 2022-06-30 | 1613000 |
| 2022-09-30 | 1387000 |
| 2022-12-31 | 3060936 |
| 2023-03-31 | 1318013 |
| 2023-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2023 | Reduced | 0 | -403,062 (-100.0%) | 0 | $0 | 2023-08-14 | |
| Q1 2023 | Reduced | 403,062 | -205,474 (-33.8%) | < 0.01% | $1,318,013 | 2023-05-15 | |
| Q4 2022 | Unchanged | 608,536 | 0 (0.0%) | 0.02% | $3,060,936 | 2023-02-14 | |
| Q3 2022 | Unchanged | 608,536 | 0 (0.0%) | < 0.01% | $1,387,000 | 2022-11-15 | |
| Q2 2022 | Unchanged | 608,536 | 0 (0.0%) | < 0.01% | $1,613,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 608,536 | -210,209 (-25.7%) | < 0.01% | $834,000 | 2022-05-16 | |
| Q4 2021 | New | 818,745 | +818,745 (0.0%) | < 0.01% | $2,595,000 | 2022-02-14 |
Who else reported the position
41 managers reported COMPASS THERAPEUTICS INC for Q1 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Unchanged | 21,642,975 | 0 | 0.49% | $29,651,000 | 2 qtrs |
| FMR LLC | Unchanged | 6,872,414 | 0 | < 0.01% | $9,415,207 | 2 qtrs |
| Rock Springs Capital Management LP | Unchanged | 5,328,088 | 0 | 0.18% | $7,299,000 | 2 qtrs |
| Foresite Capital Management V LLC | Unchanged | 4,400,000 | 0 | 2.46% | $6,028,000 | 2 qtrs |
| JANUS HENDERSON GROUP PLC | Added | 3,193,294 | +1,720,683 | < 0.01% | $4,327,000 | 2 qtrs |
| CHI Advisors LLC | Reduced | 2,829,712 | -193,980 | 1.65% | $3,877,000 | 2 qtrs |
| ADAGE CAPITAL PARTNERS GP L L C | Added | 2,277,000 | +877,000 | < 0.01% | $3,119,000 | 2 qtrs |
| Avidity Partners Management LP | Unchanged | 2,000,000 | 0 | 0.06% | $2,740,000 | 2 qtrs |
| Vivo Capital LLC | Unchanged | 2,000,000 | 0 | 0.19% | $2,740,000 | 2 qtrs |
| VANGUARD GROUP INC | Unchanged | 1,572,882 | 0 | < 0.01% | $2,155,000 | 2 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2022
- Filed
- May 16, 2022
- Filing type
- 13F-HR
- Position type
- Common
Voting authority reported
- Sole
- 608,536
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.